Covid Nasal Spray: A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of ...

Even as the global medical community continues to look for ways to cure and prevent Covid-19, a Mumbai-based pharmaceutical company has tested a nasal spray that has shown to effectively cure Covid-19 ...

Glenmark Pharmaceuticals Limited and Canadian pharmaceutical company SaNOtize Research & Development Corp. has announced the launch of FabiSpray, a nitric oxide nasal spray (NONS), for the treatment ...

Glenmark Pharmaceuticals and its strategic partner SaNOtize Research and Development Corp published their peer-reviewed Phase 3 clinical trials of their Nitric Oxide Nasal Spray (NONS) in the medical ...

Virpax Pharmaceuticals Inc (NASDAQ: VRPX) has announced preclinical results of MMS019, its anti-viral product candidate for respiratory viruses. MMS019 is a high-density molecular masking spray the ...

A nasal spray administered in high-risk adult COVID-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of phase 3 trial of the ...

A nasal spray administered in high-risk adult Covid-19 patients in India reduced viral load by 94 per cent within 24 hours and 99 per cent in 48 hours, according to the results of phase 3 trial of the ...

The trial evaluated a seven-day treatment of NONS plus standard of care versus placebo nasal spray and standard care in patients with symptomatic COVID-19. (Representational image: Reuters) A nasal ...